Research Article
Prevalence, Risk Factors, and Mortality of Patients Presenting with Moderate and Severe Hyponatremia in Emergency Departments
Table 1
Baseline characteristics of the 257 patients grouped according to the severity of hyponatremia (univariate associations).
| | Group 1: Na = 121–130 mmol/L n = 185 (65.1%) | Group 2: Na ≤ 120 mmol/L n = 99 (34.9%) | Total | Chi-square |
| Demographics: | Age | >65 | 98 (53.0%) | 72 (72.7%) | 170 (59.9%) | 0.001 | <65 | 87 (47.0%) | 27 (27.3%) | 114 (40.1%) | Mean age (year) ± SD | 69.9 ± 14.16 | 65.65 ± 15 | 67.13 ± 14.8 | | Gender | Male | 80 (43.2%) | 35 (35.4%) | 115 (40.5%) | 0.12 | Female | 105 (56.8%) | 64 (64.9%) | 169 (59.5%) |
| Blood pressure: (Mean) | Systolic blood pressure | 133 ± 29.8 | 134.04 ± 31.4 | 133.7 ± 30.83 | 0.77 | Diastolic blood pressure | 72 ± 18.44 | 74 ± 17.75 | 73 ± 19 | 0.87 | Heart rate | 78.5 ± 18.32 | 83.7 ± 16.85 | 81.9 ± 17.52 | 0.27 |
| Biochemical values: (Mean) | Potassium (mmol/L) | 4.43 ± 0.96 | 4.7 ± 3.0 | 4.62 ± 2.52 | 0.4 | Serum albumin (g/L) | 31.6 ± 13.8 | 28.5 ± 15.9 | 29.6 ± 15.2 | 0.2 | Serum hemoglobin level (g/L) | 118.2 ± 30.0 | 118.9 ± 36.0 | 118.6 ± 34.0 | 0.9 | Serum creatinine (mmol/L) | 128.0 ± 141.0 | 123.1 ± 164.7 | 128.0 ± 141.0 | 0.5 | Serum glucose (mmol/L) | 10.4 ± 6.0 | 10.0 ± 5.6 | 10.2 ± 5.7 | 0.9 |
| Comorbidities: | Diabetes | 114 (61.6%) | 69 (69.7%) | 183 (64%) | 0.18 | Hypertension | 140 (75.7%) | 82 (82.8%) | 222 (77.9%) | 0.16 | Cardiac disease | 65 (35.1%) | 44 (44.4%) | 109 (38.2%) | 0.12 | Neurological disease | 26 (14.1%) | 12 (12.1%) | 38 (13.3%) | 0.65 | Chronic pulmonary disease | 25 (13.5%) | 13 (13.1%) | 38 (13.3%) | 0.93 | Chronic liver disease | 8 (4.3%) | 10 (10.1%) | 18 (6.3%) | 0.06 | Malignancy | 21 (11.4%) | 9 (9.1%) | 30 (10.5%) | 0.56 | Chronic kidney disease | 37 (20.0%) | 22 (22.2%) | 59 (20.7%) | 0.66 | Seizure disorder | 9 (4.9%) | 2 (2%) | 11 (3.9%) | 0.24 |
| Medications: | ACEi/ARBs | 56 (30.3%) | 43 (43.4%) | 99 (34%) | 0.03 | Beta blockers | 74 (40%) | 56 (56.6%) | 130 (45.6%) | 0.008 | Thiazide diuretics | 36 (19.5%) | 15 (15.2%) | 51 (17.9%) | 0.34 | Loop diuretics | 82 (44.3%) | 52 (52.5%) | 134 (47.0%) | 0.25 | Spironolactone | 13 (7%) | 17 (56.7%) | 30 (10.5%) | 0.01 | Tricyclic antidepressants | 7 (3.8%) | 0 (0%) | 7 (2.5%) | 0.05 | Selective serotonin reuptake inhibitors | 7 (3.8%) | 2 (2.1%) | 9 (3.2%) | 0.40 | Carbamazepine | 17 (9.2%) | 9 (9.1%) | 26 (9.1%) | 0.98 | Gabapentin | 12 (6.5%) | 16 (16.2%) | 28 (9.8%) | 0.009 | Proton pump inhibitors | 93 (50.3%) | 66 (66.7%) | 159 (55.8%) | 0.008 | NSAIDs | 9 (4.9%) | 5 (5.1%) | 14 (4.9%) | 0.95 |
|
|